首页> 外文期刊>Blood Pressure Monitoring >Effect of valsartan, hydrochlorothiazide, and their combination on 24-h ambulatory blood pressure response in elderly patients with systolic hypertension: a ValVET substudy.
【24h】

Effect of valsartan, hydrochlorothiazide, and their combination on 24-h ambulatory blood pressure response in elderly patients with systolic hypertension: a ValVET substudy.

机译:缬沙坦,氢氯噻嗪及其组合对老年收缩期高血压患者24小时动态血压反应的影响:ValVET研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Stage 2 hypertension often requires combination antihypertensive therapy. Ambulatory blood pressure monitoring (ABPM) is a useful tool for studying antihypertensive drugs and their combinations. OBJECTIVE: This multicenter, double-blind, parallel-group, prompted-titration study of patients of at least 70 years of age with systolic hypertension compared the efficacy of valsartan, hydrochlorothiazide, and their combination on ambulatory blood pressure (ABP) reduction. METHODS: After a 3-14-day washout, patients with systolic blood pressure of 150-200 mmHg were randomized (1 : 1 : 1) to initially receive once-daily valsartan/hydrochlorothiazide 160/12.5 mg combination therapy, hydrochlorothiazide 12.5 mg monotherapy, or valsartan 160 mg monotherapy. Prompted uptitration of patients in whom BP was more than or equal to 140/90 mmHg was performed after 4, 8, and 12 weeks of treatment. ABPM was performed at baseline and weeks 4 and 16 (study end). RESULTS: In this ABPM substudy (n=108), initiation of treatment with valsartan/hydrochlorothiazide lowered ABP more effectively than either monotherapy throughout the daytime, night-time, and 24-h monitoring periods, as well as during the last 4 and 6-h dosing periods. Twenty-four-hour ABP was reduced from 141.1/76.5 mmHg at baseline to 125.8/69.2 mmHg at week 4 (primary time point) with valsartan/hydrochlorothiazide compared with reductions from 142.2/78.7 to 139.1/77.5 mmHg with hydrochlorothiazide and 142.2/78.3 to 136.4/75.1 mmHg with valsartan (all P<0.01 in favor of combination therapy). In the overall study, tolerability was similar among the three treatment groups. CONCLUSION: In elderly hypertensives, starting combination therapy with valsartan/hydrochlorothiazide provides more effective 24-h blood pressure control than the monotherapy components, with few therapy-related side-effects.
机译:背景:2期高血压通常需要联合降压治疗。动态血压监测(ABPM)是研究降压药及其组合的有用工具。目的:这项多中心,双盲,平行组,提示滴定研究对至少70岁的收缩期高血压患者进行了比较,比较了缬沙坦,氢氯噻嗪及其组合对降低门诊血压(ABP)的疗效。方法:经过3-14天的冲洗后,将收缩压为150-200 mmHg的患者随机分配(1:1 1:1),最初接受每日一次缬沙坦/氢氯噻嗪160 / 12.5 mg联合治疗,氢氯噻嗪12.5 mg单药治疗,或缬沙坦160毫克单一疗法。在治疗的第4、8和12周后,对BP大于或等于140/90 mmHg的患者进行了提示治疗。 ABPM在基线以及第4和16周(研究结束)进行。结果:在该ABPM子研究(n = 108)中,开始使用缬沙坦/氢氯噻嗪进行治疗比在白天,夜间和24小时监测期间以及最近4和6期间的单一疗法更有效地降低了ABP。 -h给药期。缬沙坦/氢氯噻嗪将第24小时的ABP从基线的141.1 / 76.5 mmHg降低至第4周(主要时间点)的125.8 / 69.2 mmHg,而氢氯噻嗪和142.2 / 78.3则从142.2 / 78.7降至139.1 / 77.5 mmHg缬沙坦至136.4 / 75.1 mmHg(所有P <0.01,有利于联合治疗)。在总体研究中,三个治疗组之间的耐受性相似。结论:在老年高血压患者中,开始使用缬沙坦/氢氯噻嗪的联合治疗比单药治疗更有效的24小时血压控制,且几乎没有与治疗相关的副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号